No one should suffer, especially are children.

There are approximately 68 million people in the U.S. had an STI every day in 2018...

Bioperfectus Novel Corona Virus (SARS-CoV-2) IgG/IgM Rapid Test Kit has been granted a Brazil ANVISA Registration.

Antigen tests can be used in a variety of testing strategies to respond to the COVID-19 pandemic.

Bioperfectus is pleased to invite you to join us for Bioperfectus 1st Distributors Conference & New Product Launch 2021.

Bioperfectus donates 6,000 pieces of new coronavirus nucleic acid test kits to Sister cities in Italy and Netherlands

Bioperfectus Aid Materials Greatly Enhancing Guyana's Local Testing Capabilities

Bioperfectus Assisting Namibia in Combating COVID-19!

As Thanksgiving is approaching this year, bioPerfectus would like to express our deep gratitude to all the healthcare workers fighting against the ongoing COVID-19 crisis all the around the world. For your safety and the safety of our community, let’s stay home this Thanksgiving and enjoy a safe, happy family union.

As winter moves in, COVID-19 cases, hospitalizations and the number of deaths across the world are incredibly rising. In all its various methods, testing is and will be a mainstay for the foreseeable future. However, it is critical to choose the method of testing since the best solution may be not the same during the whole progression of COVID-19.